{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:19:29Z","timestamp":1781655569804,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10067-020-05199-w","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T07:05:43Z","timestamp":1591599943000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-2083","authenticated-orcid":false,"given":"Cosimo","family":"Bruni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Nacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cometi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Tofani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"issue":"9746","key":"5199_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094\u20131108. https:\/\/doi.org\/10.1016\/S0140-6736(10)60826-4","journal-title":"Lancet"},{"issue":"10","key":"5199_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957\u2013970. https:\/\/doi.org\/10.1056\/NEJMra1505557","journal-title":"N Engl J Med"},{"issue":"26","key":"5199_CR3","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","volume":"374","author":"JD Taurog","year":"2016","unstructured":"Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563\u20132574. https:\/\/doi.org\/10.1056\/NEJMra1406182","journal-title":"N Engl J Med"},{"issue":"9783","key":"5199_CR4","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet Lond Engl 377(9783):2138\u20132149. https:\/\/doi.org\/10.1016\/S0140-6736(11)60244-4","journal-title":"Lancet Lond Engl"},{"issue":"9563","key":"5199_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet Lond Engl 369(9563):767\u2013778. https:\/\/doi.org\/10.1016\/S0140-6736(07)60363-8","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"5199_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Po\u00f3r G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2016) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210715","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5199_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41927-019-0090-7","volume":"3","author":"A Mian","year":"2019","unstructured":"Mian A, Ibrahim F, Scott DL (2019) A systematic review of guidelines for managing rheumatoid arthritis. BMC Rheumatol 3(1):42. https:\/\/doi.org\/10.1186\/s41927-019-0090-7","journal-title":"BMC Rheumatol"},{"key":"5199_CR8","doi-asserted-by":"publisher","unstructured":"Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JWJ, Burmester GR, de Wit M, Falzon L, Landew\u00e9 R (2019) Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis https:\/\/doi.org\/10.1136\/annrheumdis-2019-216656, annrheumdis-2019-216656","DOI":"10.1136\/annrheumdis-2019-216656"},{"issue":"3","key":"5199_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","volume":"75","author":"L Gossec","year":"2016","unstructured":"Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landew\u00e9 R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Ca\u00f1ete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D (2016) European league against rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499\u2013510. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208337","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5199_CR10","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Weiss PF, Beukelman T, DeWitt E, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK, American Collge of Rheumatology (2013) 2013 update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis. Arthritis Rheum 65(10):2499\u20132512. https:\/\/doi.org\/10.1002\/art.38092","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5199_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, G\u00e9her P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Comp\u00e0n V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5199_CR12","first-page":"2273","volume":"34","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Gladman D, Rahman P, Boonen A, Bykerk V, Choquette D, Dimond S, Fortin P, Karsh J, Klinkhoff AV, Mosher D, Mulholland K, Olszynski WP, Russell AS, Savage L, Shanner L, Shojania K, Starr M, Thomson G, Zummer M, Inman R, Canadian Rheumatology Association\/ Spondyloarthritis Research Consortium of Canada (2007) The Canadian rheumatology association\/ Spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project. J Rheumatol 34(11):2273\u20132284","journal-title":"J Rheumatol"},{"issue":"2","key":"5199_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/art.39298","volume":"68","author":"MM Ward","year":"2016","unstructured":"Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DTY, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of Ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol Hoboken NJ 68(2):282\u2013298. https:\/\/doi.org\/10.1002\/art.39298","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"5199_CR14","doi-asserted-by":"crossref","unstructured":"Ruiz S (2017) Biosimilars in the EU. Biosimilar Drug Prod Dev 395\u2013411","DOI":"10.1201\/9781315119878-15"},{"key":"5199_CR15","unstructured":"European Medicines Agency (2018). Imraldi. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/imraldi. Accessed 24 February 2020"},{"issue":"6","key":"5199_CR16","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/art.40444","volume":"70","author":"ME Weinblatt","year":"2018","unstructured":"Weinblatt ME, Baranauskaite A, Dokoupilova E, Zielinska A, Jaworski J, Racewicz A, Pileckyte M, Jedrychowicz-Rosiak K, Baek I, Ghil J (2018) Switching from reference adalimumab to SB5 (adalimumab biosimilar) in patients with rheumatoid arthritis: fifty-two-week phase III randomized study results. Arthritis Rheumatol Hoboken NJ 70(6):832\u2013840. https:\/\/doi.org\/10.1002\/art.40444","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"5199_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/art.40336","volume":"70","author":"ME Weinblatt","year":"2018","unstructured":"Weinblatt ME, Baranauskaite A, Niebrzydowski J, Dokoupilova E, Zielinska A, Jaworski J, Racewicz A, Pileckyte M, Jedrychowicz-Rosiak K, Cheong SY, Ghil J, Sokolovic S, Mekic M, Prodanovic N, Gajic B, Karaselimovic-Dzambasovic E, Pojskic B, Toncheva A, Dimitar P, Rodina L, Geneva-Popova M, Staykov I, Stoilov R, Podrazilova L, Mosterova Z, Simkova G, Kopackova J, Stejfova Z, Vencovsky J, Urbanova Z, Janska L, Galat\u00edkova D, Stropuviene S, Sniuoliene I, Sitek-Ziolkowska K, Rell-Bakalarska M, Kolasa R, Daniluk S, Sliwowska B, Bartosik-Twardowska M, Brzezicki J, Konieczny M, Jeka S, Choe J, Bae S, Kang Y, Prystupa L, Vyacheslav Z, Gasanov I, Yatsyshyn R, Rekalov D, Iaremenko O, Stanislavchuk M, Tseluyko V (2018) Phase III randomized study of SB5, an adalimumab biosimilar, versus reference adalimumab in patients with moderate-to-severe rheumatoid arthritis. Arthritis Rheumatol Hoboken NJ 70(1):40\u201348. https:\/\/doi.org\/10.1002\/art.40336","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"5","key":"5199_CR18","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s10067-018-4002-9","volume":"37","author":"SC Bae","year":"2018","unstructured":"Bae SC, Lee YH (2018) Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Clin Rheumatol 37(5):1199\u20131205","journal-title":"Clin Rheumatol"},{"key":"5199_CR19","doi-asserted-by":"publisher","unstructured":"Di Cesare A, Tronconi G, Fastame TM et al (2020) SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis. Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.13435","DOI":"10.1111\/dth.13435"},{"issue":"4","key":"5199_CR20","first-page":"583","volume":"32","author":"F Wolfe","year":"2005","unstructured":"Wolfe F, Michaud K, Strand V (2005) Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol 32(4):583\u2013589","journal-title":"J Rheumatol"},{"key":"5199_CR21","unstructured":"Anonymous (2019). A Real-World study of Imraldi \u00ae use (PROPER). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04089514. Accessed 05 May 2020"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05199-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05199-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05199-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:17:06Z","timestamp":1623111426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05199-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5199"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05199-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"4 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CB received honoraria from Actelion and Eli-Lilly; RB, FN, LC, LT, FB, GF: none. MMC reports receipt of grant\/research support and\/or speaker\u2019s bureau attendance from Actelion, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb, Bayer - MSD, Biogen, Eli Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Obtained from Comitato Etico Area Vasta Toscana Centro.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}